Lexeo Therapeutics, Inc. (LXEO) Total Current Liabilities (2022 - 2023)
Lexeo Therapeutics' Total Current Liabilities history spans 2 years, with the latest figure at $23.0 million for Q3 2023.
- For Q3 2023, Total Current Liabilities changed N/A year-over-year to $23.0 million; the TTM value through Sep 2023 reached $23.0 million, changed N/A, while the annual FY2022 figure was $14.3 million, N/A changed from the prior year.
- Total Current Liabilities for Q3 2023 was $23.0 million at Lexeo Therapeutics, up from $14.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $23.0 million in Q3 2023 and bottomed at $14.3 million in Q4 2022.